Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerBacterial Toxins as Pathogen Weapons Against PhagocytesStaphylococcal superantigen-like protein 3 binds to the Toll-like receptor 2 extracellular domain and inhibits cytokine production induced by Staphylococcus aureus, cell wall component, or lipopeptides in murine macrophagesStaphylococcal superantigen-like protein 10 binds to phosphatidylserine and apoptotic cells.Membrane damage elicits an immunomodulatory program in Staphylococcus aureusMolecular characterization of c-Abl/c-Src kinase inhibitors targeted against murine tumour progenitor cells that express stem cell markers.Functional basis for complement evasion by staphylococcal superantigen-like 7.Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis.Microenvironment involved in FPR1 expression by human glioblastomasThe interconnectedness of cancer cell signaling.Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3)Staphylococcal superantigen-like protein 10 (SSL10) inhibits blood coagulation by binding to prothrombin and factor Xa via their γ-carboxyglutamic acid (Gla) domainThe War on Cancer rages on.Microbial-based therapy of cancer: current progress and future prospects.Engineering of bacterial strains and their products for cancer therapy.Neutrophils and Immunity: From Bactericidal Action to Being Conquered.Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention.Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3.Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.Staphylococcus aureus modulation of innate immune responses through Toll-like (TLR), (NOD)-like (NLR) and C-type lectin (CLR) receptorsStaphylococcal superantigen-like protein 13 activates neutrophils via formyl peptide receptor 2
P2860
Q24628746-4E3C03C7-C83A-4FEB-A08D-9E45B7403D79Q26766446-023A890E-0F00-4E07-B828-F71F3923BF75Q28728050-FB7F8486-3DCE-449B-9DC1-CB189E55E14BQ30155343-FED65BD7-C06C-467A-B347-8FBA80D721E6Q33543122-6CA3D9A7-0D43-4CA5-802E-CB8B9EF5AA26Q33770326-6CEDFF46-FCB4-4089-A26E-933CD4A19924Q34137944-13A3A84C-9ECA-4997-B170-B44D141BBD34Q34291634-F7508400-1425-489F-986D-14EF4A1B53DEQ35630434-FA472302-FA0A-475B-B63C-CA113A998E96Q35669733-F72E7DD6-F80F-40F6-B38A-CBC30B8A1D7AQ36055495-B1F2CFF9-7426-4724-BE20-ED8F914EF2C1Q37048333-B0903069-C397-4DE6-B5B3-9E0D40665ECCQ37478602-FCDEF365-75AC-4CA1-B240-EAB42747A284Q37843621-E0CA8F81-E4AE-43A3-99E1-79B81CB58051Q38104247-FB587AAC-DC70-4F40-83A3-DACC900E9676Q39181244-CDE989E1-D30B-42F5-B150-61E731F4EC0CQ40697398-96C7DF4F-43AC-4E47-929E-EF0E6606BC92Q44799814-D2AA84B2-B35B-4D73-A2D6-0EF8A8EF9685Q51908452-98A42DD8-FABC-4545-84A4-C6C19770F56EQ57163788-FA7B3D09-42FF-4278-8515-E9C5CFAC9C94Q59133080-98F4B16A-BC86-43CF-9A1D-29DBBA758C36
P2860
Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.
@en
Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.
@nl
type
label
Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.
@en
Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.
@nl
prefLabel
Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.
@en
Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.
@nl
P2093
P2860
P356
P1433
P1476
Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration
@en
P2093
Annemiek M E Walenkamp
Carla J C de Haas
Dennie Rozeveld
Hetty Timmer-Bosscha
Ingrid G J Boer
Jovanka Bestebroer
Wieger Hemrika
P2860
P304
P356
10.1593/NEO.81508
P577
2009-04-01T00:00:00Z